Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Aoxin Q & M Dental GroupSGX:1D4 -2.08%44 EV-to-FCF is 683.74 as of Aug. 12, 2026, which is 12088% above its 10-year median of 5.61. GuruFocus rates SGX:1D4 with a GF Score™ of 44/100 and a GF Value™ of S$0.05 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 407 Healthcare Providers & Services companies, Aoxin Q & M Dental Group ranks worse than 98.03% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Aoxin Q & M Dental Group's Enterprise Value is S$246.15 Mil.
Aoxin Q & M Dental Group's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was S$0.36 Mil. Therefore, Aoxin Q & M Dental Group's EV-to-FCF for today is 683.74.
The historical rank and industry rank for Aoxin Q & M Dental Group's EV-to-FCF or its related term are showing as below:
SGX:1D4'
s EV-to-FCF Range Over the Past 10 Years
Min: -85.46 Med: 5.61 Max: 699.82
Current: 699.82
During the past 13 years, the highest EV-to-FCF of Aoxin Q & M Dental Group was 699.82. The lowest was -85.46. And the median was 5.61.
SGX:1D4's EV-to-FCF is ranked worse than 98.03% of 407
companies
in the Healthcare Providers & Services industry
Industry Median: 18.75
vs SGX:1D4: 699.82
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Aoxin Q & M Dental Group (SGX:1D4) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Aoxin Q & M Dental Group's PE Ratio (TTM) for today is calculated as:
Aoxin Q & M Dental Group's share price for today is S$0.235.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Aoxin Q & M Dental Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was S$0.002.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Aoxin Q & M Dental Group EV-to-FCF Related Terms
Aoxin Q & M Dental Group EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Aoxin Q & M Dental Group's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aoxin Q & M Dental Group EV-to-FCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Aoxin Q & M Dental Group's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Aoxin Q & M Dental Group's EV-to-FCF falls into.
Aoxin Q & M Dental Group's current Enterprise Value is S$246.15 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Aoxin Q & M Dental Group's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was S$0.36 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aoxin Q & M Dental Group (SGX:1D4) has a EV-to-FCF of 683.74 as of Aug. 12, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Aoxin Q & M Dental Group and its competitors. This is 12088% above median its historical median of 5.61. According to the industry distribution chart, Aoxin Q & M Dental Group ranks #399 out of 407 companies in the Healthcare Providers & Services industry, placing it in the top 98%.
Is Aoxin Q & M Dental Group's EV-to-FCF too high?
Aoxin Q & M Dental Group's current EV-to-FCF of 683.74 is 12088% above median its 10-year median of 5.61. The Healthcare Providers & Services industry median EV-to-FCF is 18.75. Aoxin Q & M Dental Group's value of 683.74 is 3546.6% above this industry median. Based on the distribution chart, Aoxin Q & M Dental Group ranks #399 out of 407 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Aoxin Q & M Dental Group has a GF Score™ of 44/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Aoxin Q & M Dental Group's EV-to-FCF compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Aoxin Q & M Dental Group ranks #399 out of 407 companies for EV-to-FCF. This places Aoxin Q & M Dental Group in the lower half of its industry. The industry median EV-to-FCF is 18.75. Aoxin Q & M Dental Group's value of 683.74 is 3546.6% above this benchmark. While the company's 10-year median is 5.61 vs. the industry median of 18.75, Aoxin Q & M Dental Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Healthcare Providers & Services company?
The median EV-to-FCF among Healthcare Providers & Services companies is 18.75, based on 407 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aoxin Q & M Dental Group's current EV-to-FCF of 683.74 is 3546.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Aoxin Q & M Dental Group and its competitors. For the Healthcare Providers & Services industry, the median EV-to-FCF is 18.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aoxin Q & M Dental Group's current EV-to-FCF is 683.74, which is 12088% above median its own 10-year median of 5.61. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aoxin Q & M Dental Group stock overvalued right now?
Based on GuruFocus' analysis, Aoxin Q & M Dental Group (SGX:1D4) is currently considered Significantly Overvalued. The stock's GF Value™ is S$0.05, compared to a current price of S$0.24 — trading 370% above its estimated fair value. The current EV-to-FCF is 683.74, which is 12088% above median its 10-year median of 5.61 and 3546.6% above the Healthcare Providers & Services industry median of 18.75. Aoxin Q & M Dental Group's overall GF Score™ is 44/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Aoxin Q & M Dental Group (SGX:1D4), the current EV-to-FCF is 683.74 as of Aug. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Aoxin Q & M Dental Group (SGX:1D4) Overvalued in 2026?
Based on GuruFocus' analysis, Aoxin Q & M Dental Group stock appears to be overvalued.
The current stock price of S$0.24 is trading 370% above its estimated GF Value™ of S$0.05.
GuruFocus considers Aoxin Q & M Dental Group to be Significantly Overvalued.
Key valuation signals for SGX:1D4:
EV-to-FCF: 683.74 (12088% above median its 10-year median of 5.61)
GF Value™: S$0.05 vs. price of S$0.24 (370% above fair value)
Industry Position: 3546.6% above the Healthcare Providers & Services median (#399 of 407)
No single metric tells the full story. See the SGX:1D4 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Aoxin Q & M Dental Group Ltd, along with its subsidiaries, offers private dental services, dental equipment, and supplies. The various dental care services offered by the Group include Stomatology and general dentistry, Endodontics, Orthodontics, Periodontics, Dental implantology, and many more. Its dental equipment and supplies portfolio includes dental chairs, ultrasound scanners, dental instruments, materials, and consumables for dental hospitals, clinics, distributors, and laboratories. The Group's reportable operating segments are: Primary healthcare, which generates the maximum revenue, Distribution of dental equipment and supplies, and Laboratory services. Geographically, it generates maximum revenue from the People's Republic of China (PRC) and the rest from Singapore.
44GF Score
Get the complete analysis for SGX:1D4
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SGX:1D4 has been successfully added to your 
